A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Friday, April 21 | 1-2 pm ET (12-1 pm CT) | Online The University of Minnesota College of Pharmacy invites all actively practicing clinicians to join their Pharmacogenomics (PGx) ECHO project. PGx ECHO aims to improve health professionals’ confidence in using PGx in patient care by providing case-based education and consultation through telementoring. Every month, […]
Friday, May 19 | 1-2 pm ET (12-1 pm CT) | Online The University of Minnesota College of Pharmacy invites all actively practicing clinicians to join their Pharmacogenomics (PGx) ECHO project. PGx ECHO aims to improve health professionals’ confidence in using PGx in patient care by providing case-based education and consultation through telementoring. Every month, […]
Monday, June 5 - Friday, June 9 | Online Genomics is becoming an increasingly important part of patient care, but healthcare providers may not be aware of genomics education resources that are available. The National Human Genome Research Institute and its partners are organizing a social media campaign from June 5 to June 9, 2023, […]
Friday, June 16 | 1-2 pm ET (12-1 pm CT) | Online The University of Minnesota College of Pharmacy invites all actively practicing clinicians to join their Pharmacogenomics (PGx) ECHO project. PGx ECHO aims to improve health professionals’ confidence in using PGx in patient care by providing case-based education and consultation through telementoring. Every month, […]
Friday, July 21 | 1-2 pm ET (12-1 pm CT) | Online The University of Minnesota College of Pharmacy invites all actively practicing clinicians to join their Pharmacogenomics (PGx) ECHO project. PGx ECHO aims to improve health professionals’ confidence in using PGx in patient care by providing case-based education and consultation through telementoring. Every month, […]
Thursday, September 14 | 12-1 p.m. ET | Online CDC Webinar: The Promise and Challenges of Implementing Pharmacogenomics to Improve Population Health: Where Are we Heading with Preemptive Pharmacogenomic Screening? Individual variability in drug response efficacy or safety is becoming an increasing problem globally, given the growing population of older adults. Reasons for this variability […]
Personalized Therapeutics: Clinical Reality and Future Challenges Thursday, February 15 | 9 a.m. ET | Virtual Speaker: George P. Patrinos Dr. Patrinos is a professor of pharmacogenomics and pharmaceutical biotechnology in the University of Patras’ (Greece) Department of Pharmacy, and holds adjunct professorships at Erasmus MC, Faculty of Medicine, Rotterdam (the Netherlands) and the United Arab […]
PGRN 2025 Scientific Meeting - in collaboration with ClinPGx September 10 – 12 | Missoula, Montana The Pharmacogenomics Global Research Network Scientific Meeting, in collaboration with ClinPGx, will be held at the University of Montana University Center in Missoula, Montana. To learn more, visit the conference webpage. Please note: Registration is required.
8th European Society of Pharmacogenomics and Personalized Therapy Congress November 5 – 8 | Rotterdam, The Netherlands ESPT 2025 will convene global experts across research, healthcare, regulation, and industry to advance pharmacogenomics and personalized therapy. The four-day program features 40+ world-class speakers, symposia, workshops, poster sessions, and discussions on topics including clinical implementation, oncology, psychiatry, […]
4th World Congress on Precision and Personalized Medicine November 27 – 28 | Zurich, Switzerland This global meeting will convene researchers, clinicians, policymakers, and industry leaders to advance innovation in precision and personalized healthcare. With the theme “Precision Medicine: Pioneering Healthcare Breakthroughs for a Healthier Future,” the program spans genomics, pharmacogenomics, biomarkers, targeted therapies, AI, […]
GMKB